AIMS/HYPOTHESIS: It is currently not clear how to construct a time- and cost-effective screening strategy for gestational diabetes mellitus (GDM). Thus, we elaborated a simple screening algorithm combining (1) fasting plasma glucose (FPG) measurement; and (2) a multivariable risk estimation model focused on individuals with normal FPG levels to decide if a further OGTT is indicated. METHODS: A total of 1,336 women were prospectively screened for several risk factors for GDM within a multicentre study conducted in Austria. Of 714 women (53.4%) who developed GDM using recent diagnostic guidelines, 461 were sufficiently screened with FPG. A risk prediction score was finally developed using data from the remaining 253 women with GDM and 622 healthy women. The screening algorithm was validated with a further 258 pregnant women. RESULTS: A risk estimation model including history of GDM, glycosuria, family history of diabetes, age, preconception dyslipidaemia and ethnic origin, in addition to FPG, was accurate for detecting GDM in participants with normal FPG. Including an FPG pretest, the receiver operating characteristic AUC of the screening algorithm was 0.90 (95% CI 0.88, 0.91). A cut-off value of 0.20 was able to differentiate between low and intermediate risk for GDM with a high sensitivity. Comparable results were seen with the validation cohort. Moreover, we demonstrated an independent association between values derived from the risk estimation and macrosomia in offspring (OR 3.03, 95% CI 1.79, 5.19, p < 0.001). CONCLUSIONS/ INTERPRETATION: This study demonstrates a new concept for accurate but cheap GDM screening. This approach should be further evaluated in different populations to ensure an optimised diagnostic algorithm.
AIMS/HYPOTHESIS: It is currently not clear how to construct a time- and cost-effective screening strategy for gestational diabetes mellitus (GDM). Thus, we elaborated a simple screening algorithm combining (1) fasting plasma glucose (FPG) measurement; and (2) a multivariable risk estimation model focused on individuals with normal FPG levels to decide if a further OGTT is indicated. METHODS: A total of 1,336 women were prospectively screened for several risk factors for GDM within a multicentre study conducted in Austria. Of 714 women (53.4%) who developed GDM using recent diagnostic guidelines, 461 were sufficiently screened with FPG. A risk prediction score was finally developed using data from the remaining 253 women with GDM and 622 healthy women. The screening algorithm was validated with a further 258 pregnant women. RESULTS: A risk estimation model including history of GDM, glycosuria, family history of diabetes, age, preconception dyslipidaemia and ethnic origin, in addition to FPG, was accurate for detecting GDM in participants with normal FPG. Including an FPG pretest, the receiver operating characteristic AUC of the screening algorithm was 0.90 (95% CI 0.88, 0.91). A cut-off value of 0.20 was able to differentiate between low and intermediate risk for GDM with a high sensitivity. Comparable results were seen with the validation cohort. Moreover, we demonstrated an independent association between values derived from the risk estimation and macrosomia in offspring (OR 3.03, 95% CI 1.79, 5.19, p < 0.001). CONCLUSIONS/ INTERPRETATION: This study demonstrates a new concept for accurate but cheap GDM screening. This approach should be further evaluated in different populations to ensure an optimised diagnostic algorithm.
Authors: Christian S Göbl; Latife Bozkurt; Thomas Prikoszovich; Christine Winzer; Giovanni Pacini; Alexandra Kautzky-Willer Journal: Obstet Gynecol Date: 2011-07 Impact factor: 7.661
Authors: M E Griffin; M Coffey; H Johnson; P Scanlon; M Foley; J Stronge; N M O'Meara; R G Firth Journal: Diabet Med Date: 2000-01 Impact factor: 4.359
Authors: A Kautzky-Willer; D Bancher-Todesca; R Weitgasser; T Prikoszovich; H Steiner; N Shnawa; G Schernthaner; R Birnbacher; B Schneider; Ch Marth; M Roden; M Lechleitner Journal: J Clin Endocrinol Metab Date: 2008-02-19 Impact factor: 5.958
Authors: Latife Bozkurt; Christian S Göbl; Lisa Pfligl; Karoline Leitner; Dagmar Bancher-Todesca; Anton Luger; Sabina Baumgartner-Parzer; Giovanni Pacini; Alexandra Kautzky-Willer Journal: J Clin Endocrinol Metab Date: 2015-01-09 Impact factor: 5.958
Authors: Grammata Kotzaeridi; Julia Blätter; Daniel Eppel; Ingo Rosicky; Martina Mittlböck; Gülen Yerlikaya-Schatten; Christian Schatten; Peter Husslein; Wolfgang Eppel; Evelyn A Huhn; Andrea Tura; Christian S Göbl Journal: Eur J Clin Invest Date: 2021-06-18 Impact factor: 5.722
Authors: Michael Feichtinger; Tina Stopp; Sandra Hofmann; Stephanie Springer; Sophie Pils; Alexandra Kautzky-Willer; Herbert Kiss; Wolfgang Eppel; Andrea Tura; Latife Bozkurt; Christian S Göbl Journal: Diabetologia Date: 2016-10-18 Impact factor: 10.122